Intellia Therapeutics Inc. (NTLA)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Caribou	$26.78	550,645	$14,746,273.10	3,994,355	2018-01-29	Filing
Novartis Large Shareholder	$18.30	1,523,000	$27,870,900.00	4,129,903	2017-12-12	Filing
Bermingham Officer, Director	$20.82	94,143	$1,960,151.40	458,250	2017-12-08	Filing
Bermingham Officer, Director	$21.46	27,566	$591,489.18	552,393	2017-12-07	Filing
Bermingham Officer, Director	$21.05	103,574	$2,180,377.70	579,959	2017-12-07	Filing
Bermingham Officer, Director	$20.84	12,467	$259,809.79	683,533	2017-12-06	Filing
Bermingham Officer, Director	$20.28	99,033	$2,008,191.17	696,000	2017-12-06	Filing
Caribou	$0.00	1,048,846	$0.00	4,545,000	2017-09-13	Filing
Formela Director	$16.07	80,000	$1,285,560.00	3,579,788	2017-07-11	Filing
Formela Director	$16.17	40,000	$646,888.00	3,659,788	2017-07-10	Filing
Formela Director	$16.77	30,000	$502,992.00	3,699,788	2017-07-07	Filing
Atlas Large Shareholder	$16.07	80,000	$1,285,560.00	3,579,788	2017-07-11	Filing
Atlas Large Shareholder	$16.17	40,000	$646,888.00	3,659,788	2017-07-10	Filing
Atlas Large Shareholder	$16.77	30,000	$502,992.00	3,699,788	2017-07-07	Filing
Atlas Large Shareholder	$14.06	5,504	$77,410.46	0	2017-03-10	Filing
Atlas Large Shareholder	$13.85	15,628	$216,432.17	5,504	2017-03-09	Filing
Formela Director	$14.06	5,504	$77,410.46	0	2017-03-10	Filing
Formela Director	$13.85	15,628	$216,432.17	5,504	2017-03-09	Filing